BISMUTH SUBSALICYLATE TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of Bismuth Subsalicylate Tablets, identified by NSN 6505014437607 and PR number 7017499677, with a total contract value of $6.40. The award was issued on July 14, 2026, and delivery is scheduled for July 29, 2026, to Medical Air Bridge West, Kadena Air Base, Okinawa, Japan, under FOB Destination terms, meaning the contractor bears all freight costs and risk until receipt by the government at the destination. The order specifies no variance in quantity, and medical substitution is permitted only under rank 01-00904720546 05H9105, reflecting strict adherence to exact specifications. The contract is a single-line, firm-fixed-price delivery order for a commercial off-the-shelf pharmaceutical item, indicating an LPTA procurement process typical for low-value, standardized medical supplies. Payment is to be processed via the Defense Finance and Accounting Service in Columbus, Ohio, in accordance with DFARS 252.232-7003, requiring electronic invoicing through WAWF. Inspection and acceptance occur at the destination by the government, with no detailed technical specifications, packaging, preservation, or labeling standards beyond the required NSN, CAGE, and PR markings. No formal contract clauses, representations, certifications, or special requirements beyond delivery and payment terms were documented in the provided data, and the NAICS code 424210 categorizes the awardee as a pharmaceutical wholesaler with no socioeconomic status disclosed. Contract administration is managed by Lisa Quinn as the contracting officer and Shairy M. Cartagena as the local administrator, with all financial tracking governed by appropriation code 97X4930 5CBX 001 2620 S33189.